Unlike blood vessel angiogenesis, rapalogues effects on tumor-associated lymphangiogenesis are not well understood, but could provide critical additional target for mTOR inhibitors in the treatment of HNSCC. Here, MTOR is linked to head and neck squamous cell carcinoma.